Semler Scientific (SMLR) said after close Thursday that it earned $0.75 per share in quarter two 2023.
On the revenue line, the company reported $18.6 million, beating estimates by $2.6 million.
In the same quarter a year ago, the company earned $0.51 per share on revenue of $14.8 million.
The stock is up 15.21% to $27.06 after the report.
Semler Scientific's earnings expanded faster than revenues, signaling widening profit margins.
Semler Scientific Inc is a US-based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.